Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. (2020)

First Author: Folegatti PM


No abstract provided

Bibliographic Information

Digital Object Identifier:

PubMed Identifier: 32702298

Publication URI:

Type: Journal Article/Review

Volume: 396

Parent Publication: Lancet (London, England)

Issue: 10249

ISSN: 0140-6736